LENEXA, KS--(Marketwire - May 12, 2009) - Mediware Information Systems, Inc. (NASDAQ: MEDW), a provider of ClosedLoop™ clinical systems for blood and medication management, reported total revenue for its third fiscal quarter ended March 31, 2009, of $10,202,000, compared to $9,839,000 in the year ago quarter. Net income for the quarter was $483,000, or 6 cents per fully diluted share, compared to $316,000, or 4 cents per fully diluted share in the third quarter of fiscal 2008. The results for the quarter represent continuous growth this year in both sequential and year over year measurements.

Commenting on the quarter, Mediware president and chief executive officer, Thomas Mann, said: "I'm pleased to report that all categories of our business experienced a very solid quarter. New system sales and service revenues increased quarter to quarter and year over year, and we have taken the right steps operationally to insulate Mediware from the impact of the economic downturn."

Mediware's continued strong earnings growth was driven by higher revenues and complemented by the company's proactive cost management. Expense management programs resulted in a 10% reduction in quarterly SG&A costs.

"Strategic investments, including our recent acquisition of Hann's On Software, are contributing to our results," said Mann. "The Ascend pharmacy product is doing well in the smaller hospital markets and our distribution agreement with EMR provider, IntraNexus, is expected to increase sales over time. Our blood center technologies (BCT) business also continued to expand during the quarter. We added new customers as well as expanded existing relationships to broaden our market penetration."

Full press release